HR 375: A potential antipsychotic drug that interacts with dopamine D2 receptors and σ-receptors in the brain
- 1 November 1986
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 71 (2) , 224-228
- https://doi.org/10.1016/0304-3940(86)90563-x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brainLife Sciences, 1986
- Endogenous ligands for sigma opioid receptors in the brain (“sigmaphin”): Evidence from binding assaysLife Sciences, 1986
- Pharmacological effects of HR 375: A new potential antipsychotic agentDrug Development Research, 1985
- Specific Binding of [3H] phencyclidine in rat central nervous tissue: further characterization and technical considerationsBrain Research, 1983
- BW234U,(cis-9-[3–(3,5-dimethyl-1-piperazinyl)propyl]carbazole dihydrochloride): a novel antipsychotic agentJournal of Pharmacy and Pharmacology, 1982
- The hypotheses of different dopamine receptor mechanismsLife Sciences, 1981